XML 21 R6.htm IDEA: XBRL DOCUMENT v3.19.2
Consolidated Statements of Shareholders’ Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Capital Surplus
Retained Earnings
Accumulated Other Comprehensive Income (Loss), Net of Tax
Treasury Stock
Balance at beginning of period (in shares) at Dec. 31, 2017   38,734,873       1,474,861
Balance at beginning of period at Dec. 31, 2017 $ 804,479 $ 38,735 $ 508,404 $ 273,119 $ (1,280) $ (14,499)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Reclassification of stranded income tax effects (392)          
Balance at beginning of period (in shares) at Dec. 31, 2017   38,734,873       1,474,861
Balance at beginning of period at Dec. 31, 2017 804,479 $ 38,735 508,404 273,119 (1,280) $ (14,499)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock for acquisition (in shares)   10,124,491        
Issuance of common stock for acquisitions 547,127 $ 10,124 537,003      
Issuance of restricted shares (in shares)   85,855        
Issuance of restricted shares 0 $ 86 (86)      
Forfeitures of restricted shares (in shares)   (472)        
Forfeitures of restricted shares 0          
Proceeds from exercise of stock options (in shares)   67,203        
Proceeds from exercise of stock options 846 $ 67 779      
Share-based compensation 3,183   3,183      
Purchase of treasury shares (in shares)           18,427
Purchase of treasury shares (985)         $ (985)
Net income 36,047     36,047    
Dividends on common shares (7,930)     (7,930)    
Reclassification of stranded income tax effects       392 (392)  
Other comprehensive income (loss) during the period (10,899)       (10,899)  
Balance at end of period (in shares) at Jun. 30, 2018   49,011,950       1,493,288
Balance at end of period at Jun. 30, 2018 1,371,896 $ 49,012 1,049,283 301,656 (12,571) $ (15,484)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Cumulative effect of change in accounting principle 28     28    
Balance at beginning of period (in shares) at Mar. 31, 2018   39,819,918       1,492,837
Balance at beginning of period at Mar. 31, 2018 868,944 $ 39,820 559,040 296,366 (10,823) $ (15,459)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock for acquisition (in shares)   9,179,905        
Issuance of common stock for acquisitions 497,116 $ 9,180 487,936      
Issuance of restricted shares (in shares)   8,100        
Issuance of restricted shares 0 $ 8 (8)      
Forfeitures of restricted shares (in shares)   (472)        
Forfeitures of restricted shares 0          
Proceeds from exercise of stock options (in shares)   4,499        
Proceeds from exercise of stock options 33 $ 4 29      
Share-based compensation 2,286   2,286      
Purchase of treasury shares (in shares)           451
Purchase of treasury shares (25)         $ (25)
Net income 9,387     9,387    
Dividends on common shares (4,097)     (4,097)    
Other comprehensive income (loss) during the period (1,748)       (1,748)  
Balance at end of period (in shares) at Jun. 30, 2018   49,011,950       1,493,288
Balance at end of period at Jun. 30, 2018 1,371,896 $ 49,012 1,049,283 301,656 (12,571) $ (15,484)
Balance at beginning of period (in shares) at Dec. 31, 2018   49,014,925       1,514,984
Balance at beginning of period at Dec. 31, 2018 1,456,347 $ 49,015 1,051,584 377,135 (4,826) $ (16,561)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of restricted shares (in shares)   117,122        
Issuance of restricted shares 915 $ 116 799      
Forfeitures of restricted shares (in shares)   (40,423)        
Forfeitures of restricted shares (524) $ (40) (484)      
Proceeds from exercise of stock options (in shares)   7,708        
Proceeds from exercise of stock options 54 $ 8 46      
Share-based compensation 1,555   1,555      
Purchase of treasury shares (in shares)           322,764
Purchase of treasury shares (11,561)         $ (11,561)
Net income 78,809     78,809    
Dividends on common shares (9,486)     (9,486)    
Other comprehensive income (loss) during the period 21,288       21,288  
Balance at end of period (in shares) at Jun. 30, 2019   49,099,332       1,837,748
Balance at end of period at Jun. 30, 2019 1,537,121 $ 49,099 1,053,500 446,182 16,462 $ (28,122)
Balance at beginning of period (in shares) at Mar. 31, 2019   49,126,427       1,541,118
Balance at beginning of period at Mar. 31, 2019 1,495,584 $ 49,126 1,053,190 412,005 (1,178) $ (17,559)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of restricted shares (in shares)   13,328        
Issuance of restricted shares 0 $ 13 (13)      
Forfeitures of restricted shares (in shares)   (40,423)        
Forfeitures of restricted shares (524) $ (40) (484)      
Share-based compensation 807   807      
Purchase of treasury shares (in shares)           296,630
Purchase of treasury shares (10,563)         $ (10,563)
Net income 38,904     38,904    
Dividends on common shares (4,727)     (4,727)    
Other comprehensive income (loss) during the period 17,640       17,640  
Balance at end of period (in shares) at Jun. 30, 2019   49,099,332       1,837,748
Balance at end of period at Jun. 30, 2019 $ 1,537,121 $ 49,099 $ 1,053,500 $ 446,182 $ 16,462 $ (28,122)